FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:29-37 January 1, 2004 Number 1 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by De Caterina, R. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by De Caterina, R. PubMed Citation

ABSTRACT

Background Leukotrienes are inflammatory mediators generated from arachidonic acid (polyunsaturated n–6 fatty acid) by the enzyme 5-lipoxygenase. Since atherosclerosis involves arterial inflammation, we hypothesized that a polymorphism in the 5-lipoxygenase gene promoter could relate to atherosclerosis in humans and that this effect could interact with the dietary intake of competing 5-lipoxygenase substrates.

Methods We determined 5-lipoxygenase genotypes, carotid-artery intima–media thickness, and markers of inflammation in a randomly sampled cohort of 470 healthy, middle-aged women and men from the Los Angeles Atherosclerosis Study. Dietary arachidonic acid and marine n–3 fatty acids (including a competing 5-lipoxygenase substrate that reduces the production of inflammatory leukotrienes) were measured with the use of six 24-hour recalls of food intake.

Results Variant 5-lipoxygenase genotypes (lacking the common allele) were found in 6.0 percent of the cohort. Mean (±SE) intima–media thickness adjusted for age, sex, height, and racial or ethnic group was increased by 80±19 µm (95 percent confidence interval, 43 to 116; P<0.001) among carriers of two variant alleles, as compared with carriers of the common (wild-type) allele. In multivariate analysis, the increase in intima–media thickness among carriers of two variant alleles (62 µm, P<0.001) was similar in this cohort to that associated with diabetes (64 µm, P=0.01), the strongest common cardiovascular risk factor. Increased dietary arachidonic acid significantly enhanced the apparent atherogenic effect of genotype, whereas increased dietary intake of n–3 fatty acids blunted the effect. Finally, the plasma level of C-reactive protein, a marker of inflammation, was increased by a factor of 2 among carriers of two variant alleles as compared with that among carriers of the common allele.

Conclusions Variant 5-lipoxygenase genotypes identify a subpopulation with increased atherosclerosis. The observed diet–gene interactions further suggest that dietary n–6 polyunsaturated fatty acids promote, whereas marine n–3 fatty acids inhibit, leukotriene-mediated inflammation that leads to atherosclerosis in this subpopulation.

Source Information

From the Department of Preventive Medicine, Keck School of Medicine, University of Southern California (J.H.D., K.M.D., J.F., H.W.); and the Departments of Human Genetics (H.A., R.M. A.J.L.) and Medicine (A.J.L., M.M.), David Geffen School of Medicine at UCLA — both in Los Angeles.

Prof. James Dwyer and Dr. Allayee contributed equally to this article.

Address reprint requests to Prof. James Dwyer at the Keck School of Medicine, 1000 S. Fremont Ave., Unit 8, Alhambra, CA 91803-8000, or at jimdwye{at}usc.edu.

Full Text of this Article

This article has been cited by other articles:

• Wingrove, J. A., Daniels, S. E., Sehnert, A. J., Tingley, W., Elashoff, M. R., Rosenberg, S., Buellesfeld, L., Grube, E., Newby, L. K., Ginsburg, G. S., Kraus, W. E. (2008). Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis. Circ Cardiovasc Genet 1: 31-38 [Abstract] [Full Text]  
• Merched, A. J., Ko, K., Gotlinger, K. H., Serhan, C. N., Chan, L. (2008). Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22: 3595-3606 [Abstract] [Full Text]  
• Ye, Y., Lin, Y., Perez-Polo, J. R., Uretsky, B. F., Ye, Z., Tieu, B. C., Birnbaum, Y. (2008). Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production. J. Immunol. 181: 3515-3523 [Abstract] [Full Text]  
• Lefebvre, B., Pepin, J-L., Baguet, J-P., Tamisier, R., Roustit, M., Riedweg, K., Bessard, G., Levy, P., Stanke-Labesque, F. (2008). Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?. Eur Respir J 32: 113-120 [Abstract] [Full Text]  
• Simopoulos, A. P. (2008). The Importance of the Omega-6/Omega-3 Fatty Acid Ratio in Cardiovascular Disease and Other Chronic Diseases. Exp. Biol. Med. 233: 674-688 [Abstract] [Full Text]  
• Vaccarino, V., Rutledge, T., Bittner, V., Bairey Merz, C. N. (2008). Reply. J Am Coll Cardiol 51: 1991-1991 [Full Text]  
• Freiberg, J. J., Tybjaerg-Hansen, A., Sillesen, H., Jensen, G. B., Nordestgaard, B. G. (2008). Promotor Polymorphisms in Leukotriene C4 Synthase and Risk of Ischemic Cerebrovascular Disease. Arterioscler. Thromb. Vasc. Bio. 28: 990-996 [Abstract] [Full Text]  
• Wung, S.-F., Aouizerat, B. E. (2008). Candidate Genes of the 5-Lipoxygenase Pathway in Acute Coronary Syndrome: A Pilot Study. Biol Res Nurs 9: 280-292 [Abstract]  
• Herb, F., Thye, T., Niemann, S., Browne, E. N.L., Chinbuah, M. A., Gyapong, J., Osei, I., Owusu-Dabo, E., Werz, O., Rusch-Gerdes, S., Horstmann, R. D., Meyer, C. G. (2008). ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum Mol Genet 17: 1052-1060 [Abstract] [Full Text]  
• Fortunato, G., Di Taranto, M. D., Bracale, U. M., Del Guercio, L., Carbone, F., Mazzaccara, C., Morgante, A., D'Armiento, F. P., D'Armiento, M., Porcellini, M., Sacchetti, L., Bracale, G., Salvatore, F. (2008). Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 28: 594-600 [Abstract] [Full Text]  
• Peters-Golden, M., Henderson, W. R. Jr. (2007). Leukotrienes. NEJM 357: 1841-1854 [Full Text]  
• Manev, H., Manev, R. (2007). 5-Lipoxygenase as a Possible Biological Link Between Depressive Symptoms and Atherosclerosis. Arch Gen Psychiatry 64: 1333-1333 [Full Text]  
• Kaetsu, Y., Yamamoto, Y., Sugihara, S., Matsuura, T., Igawa, G., Matsubara, K., Igawa, O., Shigemasa, C., Hisatome, I. (2007). Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro. Cardiovasc Res 76: 160-166 [Abstract] [Full Text]  
• Ahluwalia, N., Lin, A. Y., Tager, A. M., Pruitt, I. E., Anderson, T. J. T., Kristo, F., Shen, D., Cruz, A. R., Aikawa, M., Luster, A. D., Gerszten, R. E. (2007). Inhibited Aortic Aneurysm Formation in BLT1-Deficient Mice. J. Immunol. 179: 691-697 [Abstract] [Full Text]  
• Schirmer, M. A., Phinney, S. D. (2007). {gamma}-Linolenate Reduces Weight Regain in Formerly Obese Humans. J. Nutr. 137: 1430-1435 [Abstract] [Full Text]  
• Worrall, B. B., Brott, T. G., Brown, R. D. Jr, Brown, W. M., Rich, S. S., Arepalli, S., Wavrant-De Vrieze, F., Duckworth, J., Singleton, A. B., Hardy, J., Meschia, J. F., for the SWISS, ISGS, and MSGD Investigators, (2007). IL1RN VNTR Polymorphism in Ischemic Stroke: Analysis in 3 Populations. Stroke 38: 1189-1196 [Abstract] [Full Text]  
• Arita, M., Ohira, T., Sun, Y.-P., Elangovan, S., Chiang, N., Serhan, C. N. (2007). Resolvin E1 Selectively Interacts with Leukotriene B4 Receptor BLT1 and ChemR23 to Regulate Inflammation. J. Immunol. 178: 3912-3917 [Abstract] [Full Text]  
• Iovannisci, D. M., Lammer, E. J., Steiner, L., Cheng, S., Mahoney, L. T., Davis, P. H., Lauer, R. M., Burns, T. L. (2007). Association Between A Leukotriene C4 Synthase Gene Promoter Polymorphism and Coronary Artery Calcium in Young Women: The Muscatine Study. Arterioscler. Thromb. Vasc. Bio. 27: 394-399 [Abstract] [Full Text]  
• Shaikh, S. R., Edidin, M. (2006). Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am. J. Clin. Nutr. 84: 1277-1289 [Abstract] [Full Text]  
• Schadt, E. E., Lum, P. Y. (2006). Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Reverse engineering gene networks to identify key drivers of complex disease phenotypes. J. Lipid Res. 47: 2601-2613 [Abstract] [Full Text]  
• Topol, E. J., Smith, J., Plow, E. F., Wang, Q. K. (2006). Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15: R117-R123 [Abstract] [Full Text]  
• Hansson, G. K. (2006). Epidemiology Complements Immunology in the Heart. Arterioscler. Thromb. Vasc. Bio. 26: 2178-2180 [Full Text]  
• Ghazalpour, A., Wang, X., Lusis, A. J., Mehrabian, M. (2006). Complex Inheritance of the 5-Lipoxygenase Locus Influencing Atherosclerosis in Mice. Genetics 173: 943-951 [Abstract] [Full Text]  
• Qiu, H., Gabrielsen, A., Agardh, H. E., Wan, M., Wetterholm, A., Wong, C.-H., Hedin, U., Swedenborg, J., Hansson, G. K., Samuelsson, B., Paulsson-Berne, G., Haeggstrom, J. Z. (2006). Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc. Natl. Acad. Sci. USA 103: 8161-8166 [Abstract] [Full Text]  
• Qiu, H., Johansson, A.-S., Sjostrom, M., Wan, M., Schroder, O., Palmblad, J., Haeggstrom, J. Z. (2006). Differential induction of BLT receptor expression on human endothelial cells by lipopolysacharide, cytokines, and leukotriene B4. Proc. Natl. Acad. Sci. USA 103: 6913-6918 [Abstract] [Full Text]  
• Lai, C.-Q., Corella, D., Demissie, S., Cupples, L. A., Adiconis, X., Zhu, Y., Parnell, L. D., Tucker, K. L., Ordovas, J. M. (2006). Dietary Intake of n-6 Fatty Acids Modulates Effect of Apolipoprotein A5 Gene on Plasma Fasting Triglycerides, Remnant Lipoprotein Concentrations, and Lipoprotein Particle Size: The Framingham Heart Study. Circulation 113: 2062-2070 [Abstract] [Full Text]  
• Tedgui, A., Mallat, Z. (2006). Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways. Physiol. Rev. 86: 515-581 [Abstract] [Full Text]  
• Sasada, S., Ogata, Y., Kobayashi, M., Hirashima, T., Kawahara, K., Matsui, K., Kawase, I. (2006). Angled Forceps Used for Transbronchial Biopsy in Which Standard Forceps Are Difficult To Manipulate: A Comparative Study. Chest 129: 725-733 [Abstract] [Full Text]  
• Friedman, A., Moe, S. (2006). Review of the Effects of Omega-3 Supplementation in Dialysis Patients. CJASN 1: 182-192 [Abstract] [Full Text]  
• Lima, J. J., Zhang, S., Grant, A., Shao, L., Tantisira, K. G., Allayee, H., Wang, J., Sylvester, J., Holbrook, J., Wise, R., Weiss, S. T., Barnes, K. (2006). Influence of Leukotriene Pathway Polymorphisms on Response to Montelukast in Asthma. Am. J. Respir. Crit. Care Med. 173: 379-385 [Abstract] [Full Text]  
• De Caterina, R., Zampolli, A., Del Turco, S., Madonna, R., Massaro, M. (2006). Nutritional mechanisms that influence cardiovascular disease. Am. J. Clin. Nutr. 83: 421S-426S [Abstract] [Full Text]  
• Ordovas, J. M (2006). Genetic interactions with diet influence the risk of cardiovascular disease. Am. J. Clin. Nutr. 83: 443S-446S [Abstract] [Full Text]  
• Kornman, K. S (2006). Interleukin 1 genetics, inflammatory mechanisms, and nutrigenetic opportunities to modulate diseases of aging. Am. J. Clin. Nutr. 83: 475S-483S [Abstract] [Full Text]  
• Duff, G. W, Libby, P., Ordovas, J. M, Reilly, P. R (2006). The future of living well to 100. Am. J. Clin. Nutr. 83: 488S-490S [Full Text]  
• Luo, M., Jones, S. M., Flamand, N., Aronoff, D. M., Peters-Golden, M., Brock, T. G. (2005). Phosphorylation by Protein Kinase A Inhibits Nuclear Import of 5-Lipoxygenase. J. Biol. Chem. 280: 40609-40616 [Abstract] [Full Text]  
• Klein-Platat, C., Drai, J., Oujaa, M., Schlienger, J.-L., Simon, C. (2005). Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am. J. Clin. Nutr. 82: 1178-1184 [Abstract] [Full Text]  
• Back, M., Bu, D.-x., Branstrom, R., Sheikine, Y., Yan, Z.-Q., Hansson, G. K. (2005). Leukotriene B4 signaling through NF-{kappa}B-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc. Natl. Acad. Sci. USA 102: 17501-17506 [Abstract] [Full Text]  
• Knoflach, M., Kiechl, S., Mayr, A., Willeit, J., Poewe, W., Wick, G. (2005). Allergic Rhinitis, Asthma, and Atherosclerosis in the Bruneck and ARMY Studies. Arch Intern Med 165: 2521-2526 [Abstract] [Full Text]  
• Ginsburg, G. S., Donahue, M. P., Newby, L. K. (2005). Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics. J Am Coll Cardiol 46: 1615-1627 [Abstract] [Full Text]  
• Topol, E. J. (2005). The Genomic Basis of Myocardial Infarction. J Am Coll Cardiol 46: 1456-1465 [Full Text]  
• Antman, E. M., DeMets, D., Loscalzo, J. (2005). Cyclooxygenase Inhibition and Cardiovascular Risk. Circulation 112: 759-770 [Full Text]  
• Cipollone, F., Mezzetti, A., Fazia, M. L., Cuccurullo, C., Iezzi, A., Ucchino, S., Spigonardo, F., Bucci, M., Cuccurullo, F., Prescott, S. M., Stafforini, D. M. (2005). Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans. Arterioscler. Thromb. Vasc. Bio. 25: 1665-1670 [Abstract] [Full Text]  
• Heller, E. A., Liu, E., Tager, A. M., Sinha, S., Roberts, J. D., Koehn, S. L., Libby, P., Aikawa, E. R., Chen, J. Q., Huang, P., Freeman, M. W., Moore, K. J., Luster, A. D., Gerszten, R. E. (2005). Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell Recruitment. Circulation 112: 578-586 [Abstract] [Full Text]  
• Leopold, J. A., Loscalzo, J. (2005). Oxidative Enzymopathies and Vascular Disease. Arterioscler. Thromb. Vasc. Bio. 25: 1332-1340 [Abstract] [Full Text]  
• Sabirsh, A., Wetterholm, A., Bristulf, J., Leffler, H., Haeggstrom, J. Z., Owman, C. (2005). Fluorescent leukotriene B4: potential applications. J. Lipid Res. 46: 1339-1346 [Abstract] [Full Text]  
• Hakonarson, H., Thorvaldsson, S., Helgadottir, A., Gudbjartsson, D., Zink, F., Andresdottir, M., Manolescu, A., Arnar, D. O., Andersen, K., Sigurdsson, A., Thorgeirsson, G., Jonsson, A., Agnarsson, U., Bjornsdottir, H., Gottskalksson, G., Einarsson, A., Gudmundsdottir, H., Adalsteinsdottir, A. E., Gudmundsson, K., Kristjansson, K., Hardarson, T., Kristinsson, A., Topol, E. J., Gulcher, J., Kong, A., Gurney, M., Thorgeirsson, G., Stefansson, K. (2005). Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction: A Randomized Trial. JAMA 293: 2245-2256 [Abstract] [Full Text]  
• Serio, K. J., Reddy, K. V., Bigby, T. D. (2005). Lipopolysaccharide induces 5-lipoxygenase-activating protein gene expression in THP-1 cells via a NF-{kappa}B and C/EBP-mediated mechanism. Am. J. Physiol. Cell Physiol. 288: C1125-C1133 [Abstract] [Full Text]  
• Moreno, P. R., Fuster, V. (2004). The year in atherothrombosis. J Am Coll Cardiol 44: 2099-2110 [Full Text]  
• Bloomgarden, Z. T. (2004). Dyslipidemia and the Metabolic Syndrome. Diabetes Care 27: 3009-3016 [Full Text]  
• Goodman, J. E., Bowman, E. D., Chanock, S. J., Alberg, A. J., Harris, C. C. (2004). Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis 25: 2467-2472 [Abstract] [Full Text]  
• Fan, Y.-Y., Ly, L. H., Barhoumi, R., McMurray, D. N., Chapkin, R. S. (2004). Dietary Docosahexaenoic Acid Suppresses T Cell Protein Kinase C{theta} Lipid Raft Recruitment and IL-2 Production. J. Immunol. 173: 6151-6160 [Abstract] [Full Text]  
• Baylin, A., Campos, H. (2004). Arachidonic Acid in Adipose Tissue Is Associated with Nonfatal Acute Myocardial Infarction in the Central Valley of Costa Rica. J. Nutr. 134: 3095-3099 [Abstract] [Full Text]  
• Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G.M., Navab, M., Fogelman, A. M. (2004). Antiinflammatory Properties of HDL. Circ. Res. 95: 764-772 [Abstract] [Full Text]  
• Mao, J. T., Tsu, I-H., Dubinett, S. M., Adams, B., Sarafian, T., Baratelli, F., Roth, M. D., Serio, K. J. (2004). Modulation of Pulmonary Leukotriene B4 Production by Cyclooxygenase-2 Inhibitors and Lipopolysaccharide. Clin. Cancer Res. 10: 6872-6878 [Abstract] [Full Text]  
• Lusis, A. J., Fogelman, A. M., Fonarow, G. C. (2004). Genetic Basis of Atherosclerosis: Part II: Clinical Implications. Circulation 110: 2066-2071 [Full Text]  
• Stocker, R., Keaney, J. F. Jr. (2004). Role of Oxidative Modifications in Atherosclerosis. Physiol. Rev. 84: 1381-1478 [Abstract] [Full Text]  
• Mehrabian, M., Allayee, H. (2004). Vascular Cross-Talk: A Conversation. Arterioscler. Thromb. Vasc. Bio. 24: 1748-1749 [Full Text]  
• Luo, M., Jones, S. M., Phare, S. M., Coffey, M. J., Peters-Golden, M., Brock, T. G. (2004). Protein Kinase A Inhibits Leukotriene Synthesis by Phosphorylation of 5-Lipoxygenase on Serine 523. J. Biol. Chem. 279: 41512-41520 [Abstract] [Full Text]  
• Huang, L., Zhao, A., Wong, F., Ayala, J. M., Struthers, M., Ujjainwalla, F., Wright, S. D., Springer, M. S., Evans, J., Cui, J. (2004). Leukotriene B4 Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes. Arterioscler. Thromb. Vasc. Bio. 24: 1783-1788 [Abstract] [Full Text]  
• Lusis, A. J., Fogelman, A. M., Fonarow, G. C. (2004). Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways. Circulation 110: 1868-1873 [Full Text]  
• Manolio, T. A., Boerwinkle, E., O'Donnell, C. J., Wilson, A. F. (2004). Genetics of Ultrasonographic Carotid Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 24: 1567-1577 [Abstract] [Full Text]  
• Back, M., Qiu, H., Haeggstrom, J. Z., Sakata, K. (2004). Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor. Am. J. Physiol. Heart Circ. Physiol. 287: H419-H424 [Abstract] [Full Text]  
• Zureik, M., Kony, S., Neukirch, C., Courbon, D., Leynaert, B., Vervloet, D., Ducimetiere, P., Neukirch, F. (2004). Bronchial Hyperresponsiveness to Methacholine Is Associated With Increased Common Carotid Intima-Media Thickness in Men. Arterioscler. Thromb. Vasc. Bio. 24: 1098-1103 [Abstract] [Full Text]